The Role of Plasmapheresis Therapy for Perioperative Management in ABO-Incompatible Adult Living Donor Liver Transplantation

Transplantation Proceedings

Volumn 38, Issue 10, 2006, Pages 3629-3632

  Ashizawa, T ^a   Matsuno, N ^a   Yokoyama, T ^a   Kihara, Y ^a   Kuzuoka, K ^a   Taira, S ^a   Konno, O ^a   Jyojima, Y ^a   Akashi, I ^a   Nakamura, Y ^a   Hama, K ^a   Iwamoto, H ^a   Iwahori, T ^a   Nagao, T ^a   Kasahara, M ^a   Tanaka, K ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PROSTAGLANDIN E1; TACROLIMUS;

ADULT; AGED; ANTIBODY TITER; ARTICLE; AUTOIMMUNE HEPATITIS; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD GROUP TYPING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMOCHROMATOSIS; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR; MALE; ORGAN DONOR; PERIOPERATIVE PERIOD; PLASMAPHERESIS; PRIORITY JOURNAL; WILSON DISEASE;

ABO BLOOD-GROUP SYSTEM; ADULT; AGED; ANTIBODY FORMATION; BLOOD GROUP INCOMPATIBILITY; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSION; LIVER DISEASES; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; PERIOPERATIVE CARE; PLASMAPHERESIS; RETROSPECTIVE STUDIES; SPLENECTOMY;

EID: 33845381123     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.10.122     Document Type: Article

References (13)

1. Kozaki K., Egawa H., Tanaka K., et al. Therapeutic strategy and the role of apheresis therapy for ABO incompatible living donor liver transplantation. Ther Apher Dial 9 (2005) 285
2. Tanabe M., Shimazu M., Wakabayashi G., et al. Intraportal infusion therapy as a novel approach to adult ABO-incompatible liver transplantation. Transplantation 73 (2002) 1959
3. Starzl T.E., Ishikawa M., Putnam C.W., et al. Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc 6 (1974) 129
4. Demetris A.J., Jaffe R., Tzakis A., et al. Antibody-mediated rejection of human orthotopic liver allografts A study of liver transplantation across ABO blood group barriers. Am J Pathol 132 (1988) 489
5. Iwaki Y., Ashizawa T., Busuttil R.W., et al. ABO matching in liver transplantation. Transplant Proc 20 (1988) 564
6. Takahashi K., Saito K., Takahara S., et al. Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan. Am J Transplant 4 (2004) 1089
7. Alexandre G.P.J., Bruyere M.D.E., Squifflet J.P., et al. Human ABO-incompatible living donor renal homografts. Neth J Med 28 (1985) 231
8. Takahashi K., Yagisawa K., Sonda K., et al. ABO-incompatible kidney transplantation in a single-center trial. Transplant Proc 25 (1993) 271
9. Gugenheim J., Samuel D., Reynes M., et al. Liver transplantation across ABO blood group barriers. Lancet 336 (1990) 519
10. Egawa H., Oike F., Buhler L., et al. Impact of recipient age on outcome of ABO-incompatible living-donor liver transplantation. Transplantation 77 (2004) 403
11. Takaya S., Iwaki Y., and Starzl T.E. Liver transplantation in positive cytotoxic crossmatch case using FK 506, high-dose steroids, and prostaglandin E1. Transplantation 54 (1992) 927
12. Kamada N., Ozawa T., Ashizawa T., et al. Effects of combined therapy with prostaglandin E1 and cyclosporine A on rat heart allograft survival. Transplant Proc 23 (1991) 2213
13. Salamon D.J., Ramsey G., Nusbacher J., et al. Anti-A production by a group O spleen transplanted to a group A recipient. Vox Sang 48 (1985) 309